Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 25;12(1):55.
doi: 10.3390/biomedicines12010055.

Hyperglycaemia and Its Prognostic Value in Patients with COVID-19 Admitted to the Hospital in Lithuania

Lina Zabuliene  1 , Ieva Kubiliute  2 , Mykolas Urbonas  3 , Ligita Jancoriene  2 , Jurgita Urboniene  4 , Ioannis Ilias  5
Affiliations

Hyperglycaemia and Its Prognostic Value in Patients with COVID-19 Admitted to the Hospital in Lithuania

Lina Zabuliene et al. Biomedicines. .

Abstract

Background and objectives: Increased blood glucose levels atadmission are frequently observed in COVID-19 patients, even in those without pre-existing diabetes. Hyperglycaemia is associated with an increased incidence of severe COVID-19 infection. The aim of this study was to evaluate the association between hyperglycaemia at admission with the need for invasive mechanical ventilation (IMV) and in-hospital mortality in patients without diabetes who were hospitalized for COVID-19 infection.

Materials and methods: This retrospective observational study was conducted at Vilnius University Hospital Santaros Clinics, Lithuania with adult patients who tested positive for severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 and were hospitalized between March 2020 and May 2021. Depersonalized data were retrieved from electronic medical records. Based on blood glucose levels on the day of admission, patients without diabetes were divided into 4 groups: patients with hypoglycaemia (blood glucose below 4.0 mmol/L), patients with normoglycaemia (blood glucose between ≥4.0 mmol/L and <6.1 mmol/L), patients with mild hyperglycaemia (blood glucose between ≥6.1 mmol/L and <7.8 mmol/L), and patients with intermittent hyperglycaemia (blood glucose levels ≥7.8 mmol/L and <11.1 mmol/L). A multivariable binary logistic regression model was created to determine the association between hyperglycaemia and the need for IMV. Survival analysis was performed to assess the effect of hyperglycaemia on outcome within 30 days of hospitalization.

Results: Among 1945 patients without diabetes at admission, 1078 (55.4%) had normal glucose levels, 651 (33.5%) had mild hyperglycaemia, 196 (10.1%) had intermittent hyperglycaemia, and 20 (1.0%) had hypoglycaemia. The oddsratio (OR) for IMV in patients with intermittent hyperglycaemia was 4.82 (95% CI 2.70-8.61, p < 0.001), and the OR was 2.00 (95% CI 1.21-3.31, p = 0.007) in those with mild hyperglycaemia compared to patients presenting normal glucose levels. The hazardratio (HR) for 30-day in-hospital mortality in patients with mild hyperglycaemia was 1.62 (95% CI 1.10-2.39, p = 0.015), while the HR was 3.04 (95% CI 2.01-4.60, p < 0.001) in patients with intermittent hyperglycaemia compared to those with normoglycaemia at admission.

Conclusions: In COVID-19 patients without pre-existing diabetes, the presence of hyperglycaemia at admission is indicative of COVID-19-induced alterations in glucose metabolism and stress hyperglycaemia. Hyperglycaemia at admission in COVID-19 patients without diabetes is associated with an increased risk of invasive mechanical ventilation and in-hospital mortality. This finding highlights the importance for clinicians to carefully consider and select optimal support and treatment strategies for these patients. Further studies on the long-term consequences of hyperglycaemia in this specific population are warranted.

Keywords: COVID-19; SARS-CoV-2; coronavirus; glucose on admission; hyperglycaemia; in-hospital mortality.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Distribution of patients hospitalized with COVID-19 infection.
Figure 2
Figure 2
Risk factors and odds ratios (OR) associated with the need for invasive mechanical ventilation in COVID-19 patients without diabetes.
Figure 3
Figure 3
Survival of hospitalized patients without diabetes stratified by glycaemia levels atadmission.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Roy S., Demmer R.T. Impaired glucose regulation, SARS-CoV-2 infections and adverse COVID-19 outcomes. Transl. Res. 2022;241:52–69. doi: 10.1016/j.trsl.2021.11.002. - DOI - PMC - PubMed
    1. Apicella M., Campopiano M.C., Mantuano M., Mazoni L., Coppelli A., Del Prato S. COVID-19 in people with diabetes:Understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8:782–792. doi: 10.1016/S2213-8587(20)30238-2. - DOI - PMC - PubMed
    1. Sharma P., Behl T., Sharma N., Singh S., Grewal A.S., Albarrati A., Albratty M., Meraya A.M., Bungau S. COVID-19 and diabetes: Association intensify risk factors fo rmorbidity and mortality. Biomed. Pharmacother. 2022;151:113089. doi: 10.1016/j.biopha.2022.113089. - DOI - PMC - PubMed
    1. Vedantam D., Poman D.S., Motwani L., Asif N., Patel A., Anne K.K. Stress-InducedHyperglycemia: Consequences and Management. Cureus. 2022;14:e26714. - PMC - PubMed
    1. Plummer M.P., Bellomo R., Cousins C.E., Annink C.E., Sundararajan K., Reddi B.A., Raj J.P., Chapman M.J., Horowitz M., Deane A.M. Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality. Intensive Care Med. 2014;40:973–980. doi: 10.1007/s00134-014-3287-7. - DOI - PubMed

LinkOut - more resources